Answers are grounded in this paper and cite their sources.
Metabolic alkalosis is common—half of all acid-base disorders as described in one study (1). This observation should not be surprising since vomiting, the use of chloruretic diuretics, and nasogastric suction are common among hospitalized patients. The mortality associated with severe metabolic alkalosis is substantial; a mortality rate of 45% in patients with an arterial blood pH of 7.55 and 80% when the pH was greater than 7.65 has been reported (2). Although this relationship is not necessarily causal, severe alkalosis should be viewed with concern, and correction by the appropriate intervention should be undertaken with dispatch when the arterial blood pH exceeds 7.55. Metabolic alkalosis occurs when a primary pathophysiologic process leads to the net accumulation of base within or the net loss of acid from the extracellular fluid (ECF); typically, the intracellular compartment becomes more acidic in potassium-depletion alkalosis (3). Unopposed by other primary acid-base disorders, metabolic alkalosis is recognized by increases in both arterial blood pH—alkalemia—and plasma bicarbonate concentration. The increase in arterial blood pH promptly, normally, and predictably depresses ventilation resulting in increased PaCO2 and the buffering of the alkalemia. The PaCO2 increases about 0.5 to 0.7 mmHg for every 1.0 mM increase in plasma HCO3 concentration (4). Although a PaCO2 greater than 55 mmHg is uncommon, compensatory increases to 60 mmHg have been documented in severe metabolic alkalosis. Failure of an appropriate compensatory increase in PaCO2 should be interpreted as a mixed acid-base disturbance in which a stimulus to hyperventilation—primary respiratory alkalosis—accompanies primary metabolic alkalosis. Classification and Definitions Metabolic alkalosis has been classified by the primary organ system involved, the response to therapy, or the underlying pathophysiology; the latter is presented in Table 1. The most common group—those due to chloride depletion—can, by definition, be corrected without potassium repletion. The other major grouping is that due to potassium depletion, usually with mineralocorticoid excess. Metabolic alkalosis due to both potassium and chloride depletion also may occur and is not rare.Table 1: Etiologies of metabolic alkalosisBicarbonate or base loading, whether exogenous or endogenous (as in bone dissolution), is rarely a sole cause of significant persistent metabolic alkalosis because the normal kidney is so efficient at excreting bicarbonate. Such transient states may occur during and immediately after an oral or intravenous infusion of NaHCO3 or base equivalent, e.g., citrate in transfused blood or fresh frozen plasma (5). They may also occur after the successful treatment of ketoacidosis or lactic acidosis, as these organic anions are metabolized to bicarbonate. Finally, after successful correction of hypercapnia in respiratory acidosis before the kidney can excrete the bicarbonate retained for compensation, metabolic alkalosis may occur transiently provided that chloride intake is adequate. In these transient states, the urinary pH should be relatively alkaline (>6.2). The course of metabolic alkalosis can be divided into generation, maintenance, and correction phases (6). Generation occurs by loss of protons from the ECF into the external environment or into the cells, or by gain of base by the oral or intravenous route or from the base stored in bone apatite. Disequilibrium occurs in the generation phase when the resultant elevation of plasma bicarbonate exceeds the capacity of the renal tubule to reabsorb bicarbonate. Transient bicarbonaturia (urinary pH >6.2) with resulting sodium loss ensues until a new steady state of chronic metabolic alkalosis is achieved and bicarbonate excretion ceases. At this point, the urine is relatively acidic—so-called paradoxical aciduria—and metabolic alkalosis is likely to be in the maintenance phase. Pathophysiology of Chloride-Depletion Alkaloses Generation Chloride may be lost from the gut, kidney, or skin. The loss of gastric fluid, which contains 60 to 140 mM HCl and lesser variable concentrations of sodium and potassium (7), results in alkalosis because bicarbonate generated during the production of gastric acid returns to the circulation. In the Zollinger-Ellison syndrome or pyloric stenosis, these losses may be massive. Although sodium and potassium loss in the gastric fluid varies in concentration, the obligate urinary loss of these cations is intensified by bicarbonaturia, which occurs during disequilibrium. Gastrocystoplasty, recently introduced for bladder augmentation, may also result in urinary HCl losses sufficient to produce alkalosis (8). Villous adenomas of the colon usually produce a hyperchloremic metabolic acidosis because of the loss of large volumes of colonic fluid, rich in potassium and bicarbonate. However, 10 to 20% of these tumors will secrete chloride rather than bicarbonate with potassium, and thus result in metabolic alkalosis (9). Congenital chloridorrhea, an autosomal recessive disease, is caused by defective apical chloride/bicarbonate exchange in the colon and perhaps the ileum because of a mutation of the Down-Regulated in Adenoma (DRA) gene (10). This defect results in copious diarrhea with major chloride losses (11). Gastric and jejunal functions are normal. Although fecal sodium and potassium concentrations are normal, the unremitting watery stool results also in sodium, potassium, and volume losses. The renal response mediated by aldosterone is intense sodium and water reabsorption at the expense of proton and potassium secretion, thereby further promoting alkalosis. Chloruretic agents such as chlorothiazide, furosemide, and their congeners all directly produce the loss of chloride, sodium, and fluid in the urine (12). These losses, in turn, promote metabolic alkalosis by several possible mechanisms. (1) Diuretic-induced increases in sodium delivery to the distal nephron accelerate potassium and proton secretion (13). (2) ECF volume contraction stimulates renin and aldosterone secretion, which blunts sodium loss but accelerates the secretion of potassium and protons. (3) Potassium depletion will independently augment bicarbonate reabsorption in the proximal tubule (14) and (4) stimulate ammonia production, which, in turn, will increase urinary net acid excretion. Urinary losses of chloride exceed those for sodium and are associated with alkalosis even when potassium depletion is prevented (15). Respiratory acidosis is compensated by accelerated renal bicarbonate reabsorption in various nephron segments and increased urinary chloride excretion (16, 17). The patient with chronic respiratory acidosis is chloride-depleted, and the kidney will maintain this deficit until the hypercapnia is corrected. When respiratory acidosis is corrected, accelerated bicarbonate reabsorption, which is no longer appropriate, persists if sufficient chloride is not available and “post-hypercapneic” metabolic alkalosis remains. Skin losses of chloride may generate alkalosis in cystic fibrosis. Alkalosis may even be the presenting feature in adolescence with a few of the several hundred mutations in the cystic fibrosis transmembrane regulator (CFTR) gene (18). Maintenance The cessation of events that generate alkalosis is not necessarily accompanied by resolution of the alkalosis. To account for maintained metabolic alkalosis in these instances, the kidney must retain bicarbonate by either a decrease in GFR with an accompanying decrease in filtered bicarbonate, or by an increase in bicarbonate reabsorption, or by both mechanisms. Because chloride-depletion alkaloses are usually characterized by concurrent deficits of sodium, potassium, and fluid, as well as chloride, controversy has arisen regarding which of these deficits is responsible for the maintenance of the alkalosis. Kassirer and Schwartz showed that experimental chloride-depletion alkalosis effected by gastric suction could be completely corrected by chloride repletion with either KCl or NaCl, thus eliminating deficits of sodium or potassium per se as specific causes of maintenance in these circumstances (19). Based on this and other studies, they concluded that chloride repletion was pivotal in the correction (20), but a role for volume repletion per se was not excluded. Subsequently, Cohen provided evidence of a primary role for volume expansion (21). A widely accepted hypothesis for the pathophysiology of the maintenance and correction of chloride-depletion alkalosis based on volume proposed the following (6): Volume contraction accompanying alkalosis augments fluid reabsorption in the proximal tubule, and, because bicarbonate is preferentially reabsorbed compared with chloride in this segment, alkalosis is maintained. With ECF volume expansion, fluid reabsorption in the proximal tubule is depressed, delivering more bicarbonate and chloride to the distal nephron, which possesses a substantial capacity to reabsorb chloride but a limited one for bicarbonate. As a result, chloride is retained, bicarbonate excreted, and alkalosis corrected. In this construct, chloride administration has only a permissive role for volume expansion, which itself is regarded as the extrarenal impetus for correction. This “classical” hypothesis based on volume has been reappraised in a series of studies of both acute and chronic chloride-depletion alkalosis in human and rat (22). In these studies, chloride-depletion alkalosis has been completely corrected by the administration of any of several non-sodium chloride salts despite persistently low GFR, decreased plasma volume, negative sodium balance, decreasing body weight, continuing urinary potassium loss, persistently high plasma aldosterone concentration, and continued bicarbonate loading—all of which would, if anything, maintain or generate alkalosis. During either expansion or contraction of ECF volume, alkalosis was not corrected without chloride replacement (23). Even during sustained volume contraction, chloride promptly induced bicarbonaturia and progressively corrected the alkalosis. In humans with diuretic-induced alkalosis maintained for 5 d by chloride restriction, alkalosis was corrected as chloride was repleted quantitatively despite decreased GFR, renal blood flow, and the decreased plasma volume that persisted throughout the correction (15). In contrast, men given equal amounts of neutral sodium phosphate became volume-expanded with worsening of their alkalosis. Thus, we would extend the earlier conclusion of Schwartz and coworkers to state that chloride is necessary and sufficient for the correction of chloride-depletion alkalosis (20). Volume depletion is a commonly associated but not a causative or essential factor for the maintenance of alkalosis. We have proposed that intrarenal mechanisms responsive to chloride depletion can plausibly account for the maintenance of alkalosis regardless of the status of the ECF volume. In the absence of volume depletion, chloride depletion appears to decrease GFR by tubuloglomerular feedback (24) by an alteration in the signal perceived by the macula densa—tubule fluid chloride concentration or osmolality. Such a protective response by the kidney would blunt fluid and sodium losses, which are likely to attend the bicarbonaturia frequently encountered during disequilibrium alkalosis. Chloride depletion also increases renin secretion by a macula densa mechanism, resulting in increased aldosterone secretion that may be disproportionate to the magnitude of an accompanying hypokalemia and thereby augment potassium wasting. Although normal functioning of the proximal tubule is essential to permit appropriate bicarbonate reabsorption, the collecting duct appears to be the major nephron site for altered electrolyte and proton transport in both maintenance of and recovery from metabolic alkalosis. The collecting duct is heterogeneous anatomically and functionally throughout its length with regard to both cells and segments, but the major cell stimulated by chloride-depletion alkalosis is the type B intercalated cell in the cortical segment (25,26). During maintenance, bicarbonate secretion does not occur because insufficient chloride is available for bicarbonate exchange and bicarbonate reabsorption is maintained distally in the medullary segments. When chloride is administered and luminal or cellular chloride concentration or amount increases, bicarbonate is promptly excreted and alkalosis is corrected. When a defect in renal transport itself is the proximate cause of alkalosis, i.e., Bartter syndrome, other alterations in renal electrolyte transport likely occur. Pathophysiology: Potassium Depletion/Mineralocorticoid Excess Alkalosis Generation Dietary potassium depletion is associated with modest metabolic alkalosis and with an increase in intracellular sodium and proton concentrations and suppression of aldosterone (27,28). Metabolic alkalosis is generated primarily by an intracellular shift of protons. However, potassium depletion is also associated with enhanced renal ammonia production, and a contribution of increased net acid excretion has not been excluded in humans (29,30). Similarly, administration of aldosterone causes only a slight degree of metabolic alkalosis if potassium depletion is prevented (31). While escape from the sodium-retaining effect of mineralocorticoids occurs at the expense of persistent intravascular and ECF volume expansion and resulting hypertension, escape does not occur from their potassium-wasting effect. When potassium depletion and mineralocorticoid excess occur together, prominent metabolic alkalosis is common. Mineralocorticoid excess either primary or secondary can occur for a myriad of causes (Table 1). Acting at its receptor in the principal cell of the collecting duct, mineralocorticoid stimulates the apical sodium channel and basolateral Na,KATPase, and increased sodium reabsorption promotes potassium secretion through the apical potassium channel. Associated sodium retention usually leads to hypertension, as in primary aldosteronism, or often to edema, as in secondary aldosteronism, e.g., in cardiac failure. Low plasma renin and high circulating aldosterone characterize the primary disorders, whereas high plasma renin and aldosterone characterize the secondary causes. Most all of the primary disorders are due to adrenal neoplasia or hyperplasia except the glucocorticoid-suppressible variety. This autosomal dominant disease is caused by a chimeric gene formed by the overlap of the gene for 11 β-hydroxylase with that for aldosterone synthase (32). The former is regulated by adrenocorticotropin hormone (ACTH), whereas the latter normally is not. As a consequence of this chimera, aldosterone secretion becomes responsive to and aldosterone excess mineralocorticoid excess have more and are associated with low circulating aldosterone and low plasma of these alterations in the for are in and and a for the treatment of acid or its either of which the renal of 11 only in the principal This normally which exceeds the concentration of aldosterone by a of to the Thus, with these at the mineralocorticoid In contrast, syndrome, an autosomal dominant with variable is characterized by a defect in a of the apical sodium channel in the principal cell of the collecting duct that leads to sodium reabsorption with the of events as of potassium depletion likely to the renal maintenance of metabolic alkalosis. Potassium secretion is stimulated by enhanced luminal sodium increased aldosterone increased cellular potassium or of luminal tubule bicarbonate reabsorption is enhanced and may be secondary to intracellular acidosis, which proton In the cortical collecting tubule, aldosterone stimulates proton secretion and bicarbonate reabsorption either directly or by an increased A intercalated cells in the medullary segment increase in and in potassium depletion and may be in potassium at the expense of continued bicarbonate reabsorption through both and The role of intracellular acidosis in potassium-depletion alkalosis is by correction of the alkalosis by infusion of potassium without any suppression of renal net acid excretion correction is to occur by the of potassium into and of protons of the which ECF bicarbonate. disorders may be characterized by both chloride and potassium depletion, which to the alkalosis. They are usually associated with sodium losses and or of chloride occurs in potassium depletion and thus severe potassium depletion, in is accompanied by renal chloride wasting. Alkalosis in Bartter and and their are likely on both potassium and chloride Most patients with are usually in with to A primary defect in reabsorption in the of renal sodium, potassium, and chloride macula densa and volume of the and high renal production of excess and severe potassium depletion can further reabsorption in the is prominent concentration is usually normal. is severe in likely because the mutation is in the luminal which potassium from the of into the essential for the normal functioning of the In contrast, often in is is often and, at in the is more common than The defect in this syndrome is in the in the distal tubule is associated with and but not increased urinary potassium losses such as in or are rarely associated with severe alkalosis. Urinary potassium is low in and plasma bicarbonate is rarely to Pathophysiology: syndrome in which both bicarbonate and are alkalosis by several vomiting, increases bicarbonate and a in high can cause alkalosis by bicarbonate to the causes metabolic alkalosis because of the of the negative that normally to the and the shift in the buffering for and The of metabolic alkalosis per se are to from those of chloride, volume, or potassium cardiac and in to a low plasma are common when alkalosis is severe may cause or to in or patients. The cause of chronic metabolic alkalosis is often on the of the patient with a and (Table 1). In the absence of blood an increase in the primarily to hypokalemia the of metabolic alkalosis respiratory acidosis when plasma chloride is low and bicarbonate Urinary chloride and potassium before are Low urinary chloride alkalosis in which chloride depletion a chloruretic is low until chloride repletion is A urinary potassium concentration of in the of hypokalemia renal potassium which is of an renal diuretics, or high circulating a urinary potassium concentration of extrarenal potassium When metabolic alkalosis due primarily to potassium depletion is the of a severe alkalosis should a for causative such as chloride depletion or base the cause of the alkalosis is not the urine should be for of alkalosis as with or can be to but may to the The patients are more often an underlying may be the of alkalosis may the patient can alkaline urine can occur with patients with may have and usually leads to more severe potassium depletion than is in (1) correction of deficits and (2) of continuing losses. With regard to the or other that generate alkalosis should be Alkaloses Although replacement of the chloride deficit is of the accompanying potassium, or on of ECF volume the and degree of associated potassium depletion, and the degree and of any of kidney is normal, bicarbonate and base will be excreted with sodium or potassium and metabolic alkalosis will be corrected as chloride is depletion of chloride and ECF volume as is most is the appropriate and both In patients with of volume contraction, the administration of a of to 5 of is usually necessary to volume deficits and metabolic alkalosis. When the ECF volume is as normal, body chloride deficit can be by the in plasma chloride The replacement of continuing losses of fluid and must be to this As the chloride deficit is corrected, a alkaline will occur with a decrease in plasma bicarbonate normal. potassium concentration should be potassium repletion is to other of potassium Potassium can be provided by KCl 10 to to the In the of volume such as in administration of is Chloride should be repleted with KCl as is or if the to excrete a potassium is a HCl is if or KCl is and correction should be i.e., when the arterial pH is greater than and in the of cardiac or altered The amount of given as or to alkalosis is by the 0.5 in plasma bicarbonate continuing losses must also be The use of of body as the volume of of protons to the buffering of those in intracellular protons must these as well as extracellular bicarbonate. Because the of such is to the patient from severe alkalosis, is usually to to the plasma bicarbonate concentration normal. HCl must be given through a in the or a large The of the should be because of HCl can to of in the this could be a of infusion to have been These patients are in an with of arterial blood and is an which may be given into a its rate of infusion should not exceed is by the of renal or In concurrent renal would be and, in acute ammonia with could or HCl should be because they have been associated with GFR is the use of to which a of primarily NaHCO3 by of can be When high sodium excretion must be maintained or if a high potassium is is can be sustained metabolic alkalosis is is KCl should be administered because of the high of hypokalemia during the alkaline When the kidney is of to chloride repletion or is necessary for the of renal exchange of bicarbonate for chloride by or will metabolic alkalosis. The for both and which high concentrations of bicarbonate or its metabolic must be in these In an can be of with appropriate maintenance of plasma potassium, and concentrations by intravenous are in specific associated with chloride-depletion metabolic alkalosis. In the of or the for the of gastric metabolic alkalosis will to be generated and replacement of deficits will be by these losses. In such the administration of a proton such as will blunt gastric acid may also be have also been to blunt the acid loss that occurs with Congenital is responsive to continued repletion of fluid, chloride, and potassium losses by of the whereas agents are in gastric HCl production by proton has been to in the maintenance of chloride Villous adenomas Alkaloses When potassium depletion is associated with a metabolic alkalosis, oral KCl to 60 or per usually will for correction. a cardiac or is intravenous KCl may be given at as high as in concentrations not to exceed 60 These high should be only when are The patient should be by and of plasma potassium concentration because of potassium may be by of should be from the to potassium because stimulated secretion may cause plasma potassium concentration to decrease even However, potassium repletion has the of in the infusion will cellular potassium repletion. Because due to potassium depletion may water plasma sodium should be if are When mineralocorticoid excess is the proximate is at either of the or its diuretics, with will the of mineralocorticoid excess on sodium, potassium, and bicarbonate excretion. of sodium and the of potassium to the will also the alkalosis and the of the potassium deficit the but of aldosterone excess is essential to correction. In glucocorticoid-suppressible and is the of to primary disorders of mineralocorticoid excess are by tumors may be by or With adrenal either or as appropriate, may be In the syndrome, the treatment of the can rarely be In this and in adrenal which the in or which the in will blunt the myriad of In those disorders in which be which of the and and aldosterone production or has also been to of the of the However, to the that severe fluid and electrolyte are due to aldosterone production, may not when alkalosis is or would be of the use of these is the of this In and the principal of is to urinary potassium In which production and decrease aldosterone secretion, have been to be and should be Because renal production is increased in and may to sodium, chloride, and potassium synthase may but usually will not completely the alkalosis. depletion, which may also increase urinary potassium should be corrected. However, the degree to which repletion alkalosis is and salts often produce an degree of that may the In diuretics, such as 5 or 10 a or to a will blunt the urinary losses but potassium may also be When intake or should be In syndrome, is a In the syndrome, cessation of and the and and chloride and volume repletion for the commonly associated vomiting, usually will to the resolution of these
No takes yet. Share an insight, caveat, or question.
John H. Galla (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: